Contact details
Dr Sarah Burl
Research Associate
Department of Medicine
235
Wright Fleming Wing
St Mary's Campus
Tel: +44 (0)20 7594 2063
Email:
Dr Sarah Burl
I am a newly appointed Research Associate (October 2010) working in the area of infant immunology and vaccines. The previous seven years I have spent in The Gambia working with several infant cohorts looking at BCG immunogenicity and more recently assessing the immune responses of infants to TLR agonists. At Imperial I am working in Beate Kampmann's group continuing with collaborative work between The Gambia and the UK investigating early life immunity to vaccines and infectious diseases.
Selected Publications
Journals
- Burl S; Adetifa UJ; Cox M; Touray E; Ota MO; Marchant A; Whittle H; McShane H; et alRowland-Jones SL; Flanagan KL. (15 Aug 2010). Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age. J Immunol. 185:2620-2628. DOI.
- Flanagan KL; Burl S; Lohman-Payne BL; Plebanski M. (Jun 2010). The challenge of assessing infant vaccine responses in resource-poor settings. Expert Rev Vaccines. 9:665-674. DOI.
- Flanagan KL; Halliday A; Burl S; Landgraf K; Jagne YJ; Noho-Konteh F; Townend J; Miles DJ; et alvan der Sande M; Whittle H; Rowland-Jones S. (Apr 2010). The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth. Eur J Immunol. 40:1062-1072. DOI.
- Burl S; Adetifa UJ; Cox M; Touray E; Whittle H; McShane H; Rowland-Jones SL; Flanagan KL. (2010). The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life. PLoS One. 5:e12287. DOI.
- Burl S; Hill PC; Jeffries DJ; Holland MJ; Fox A; Lugos MD; Adegbola RA; Rook GA; et alZumla A; McAdam KP; Brookes RH. (Jul 2007). FOXP3 gene expression in a tuberculosis case contact study. Clin Exp Immunol. 149:117-122. DOI.
